Part 3 of a study to evaluate the safety of a single dose of increasing amounts of INO-4885 given via a vein to healthy adult male volunteers
Phase 1
- Conditions
- o specific health condition being studied - the study is being conducted for safety reasons in healthy male volunteers that do not belong to any target population for the given interventionNo specific health condition being studied - the study is being conducted for safety reasons in healthy male volunteers that do not belong to any target population for the given interventionOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)
- Registration Number
- ACTRN12608000412336
- Lead Sponsor
- Inotek Pharmaceuticals Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
Subject's body weight between 65 and 100 kg and Body Mass Index between 18 and 29, inclusive.
Exclusion Criteria
Subject received treatment or participated in a study with any investigational product within 30 days prior to study drug administration; subject used tobacco, alcohol, caffeine, vitamins, or herbal medications within 48 hours prior to study drug administration; subject used or required any prescription medications during the 4 weeks prior to study drug administration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method